Podcasts about foamix pharmaceuticals

  • 5PODCASTS
  • 7EPISODES
  • 39mAVG DURATION
  • ?INFREQUENT EPISODES
  • Apr 24, 2019LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about foamix pharmaceuticals

Latest podcast episodes about foamix pharmaceuticals

TechNation Radio Podcast
Episode 19-17 The Advantages of “Unsafe Thinking”

TechNation Radio Podcast

Play Episode Listen Later Apr 24, 2019 59:00


On this week’s Tech Nation, Fast Company columnist Jonah Sachs. His book is “Unsafe Thinking: How to Be Nimble and Bold When You Need It Most”. Then on Tech Nation Health, Dr. Tom Lowery from T2 Biosystems – their part in fighting life-threatening Sepsis. And David Domzalski from Foamix Pharmaceuticals talks about a new approach to America’s most common skin disorder: Acne.

america thinking fast company advantages acne unsafe sepsis tech nation jonah sachs be nimble t2 biosystems unsafe thinking how bold when you need it most foamix pharmaceuticals tech nation health
BioTech Nation Radio Podcast
Episode 19-17 The Advantages of “Unsafe Thinking”

BioTech Nation Radio Podcast

Play Episode Listen Later Apr 24, 2019 59:00


On this week’s Tech Nation, Fast Company columnist Jonah Sachs. His book is “Unsafe Thinking: How to Be Nimble and Bold When You Need It Most”. Then on Tech Nation Health, Dr. Tom Lowery from T2 Biosystems – their part in fighting life-threatening Sepsis. And David Domzalski from Foamix Pharmaceuticals talks about a new approach to America’s most common skin disorder: Acne.

america thinking fast company advantages acne unsafe sepsis tech nation jonah sachs be nimble t2 biosystems unsafe thinking how bold when you need it most foamix pharmaceuticals tech nation health
FirstWord Pharmaceutical News
FirstWord Pharmaceutical News for Wednesday, November 07 2018

FirstWord Pharmaceutical News

Play Episode Listen Later Nov 7, 2018 4:44


Today in FirstWord:

BioTech Nation Radio Podcast
Episode 18-33 The Advantages of “Unsafe Thinking”

BioTech Nation Radio Podcast

Play Episode Listen Later Aug 20, 2018 59:00


On this week’s Tech Nation, Fast Company columnist Jonah Sachs. His book is “Unsafe Thinking: How to Be Nimble and Bold When You Need It Most”. Then on Tech Nation Health, Dr. Tom Lowery (“L’ow!-ree”) from T2 Biosystems – their part in fighting life-threatening Sepsis. And David Domzalski from Foamix Pharmaceuticals talks about a new approach to America’s most common skin disorder: Acne.

america thinking fast company advantages acne unsafe sepsis tech nation jonah sachs be nimble t2 biosystems unsafe thinking how bold when you need it most foamix pharmaceuticals tech nation health
TechNation Health Podcast
Episode 18-33 A new approach to the most common skin disorder: Acne

TechNation Health Podcast

Play Episode Listen Later Aug 20, 2018 20:05


On this week’s Tech Nation Health, Dr. Tom Lowery (“L’ow!-ree”) from T2 Biosystems – their part in fighting life-threatening Sepsis. And David Domzalski from Foamix Pharmaceuticals talks about a new approach to America’s most common skin disorder: Acne.

america skin disorders acne new approach sepsis t2 biosystems foamix pharmaceuticals tech nation health
TechNation Radio Podcast
Episode 18-33 The Advantages of “Unsafe Thinking”

TechNation Radio Podcast

Play Episode Listen Later Aug 17, 2018 59:00


On this week’s Tech Nation, Fast Company columnist Jonah Sachs. His book is “Unsafe Thinking: How to Be Nimble and Bold When You Need It Most”. Then on Tech Nation Health, Dr. Tom Lowery (“L’ow!-ree”) from T2 Biosystems – their part in fighting life-threatening Sepsis. And David Domzalski from Foamix Pharmaceuticals talks about a new approach to America’s most common skin disorder: Acne.

america thinking fast company advantages acne unsafe sepsis tech nation jonah sachs be nimble t2 biosystems unsafe thinking how bold when you need it most foamix pharmaceuticals tech nation health
Empowered Patient Podcast
Innovative Topical Treatment of Acne with Dave Domzalski Foamix

Empowered Patient Podcast

Play Episode Listen Later Jun 27, 2018 15:17


Dave Domzalski, CEO, Foamix Pharmaceuticals reminds us that acne is the most common skin condition affecting 50 million people in the US alone, how little has changed in the treatment of outbreaks, and how side effects of commonly prescribed acne treatments often result in many people discontinuing use leaving their acne unresolved.  Foamix is in late stage development of a topical form of minocycline, usually prescribed as an oral antibiotic, that is applied directly to the skin as a foam and that is showing fewer side-effects and greater impact. #acne #acneprone #AcneAwareness #skincare #clearskin #dermatology #dermatologist  Foamix Pharmaceuticals